Estimating the lifetime risk of a false positive screening test result
PLOS ONE · 15.02.2023 · 18 (2) · e0281153
DOI: 10.1371/journal.pone.0281153 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 15.02.2023. Verfasst von Tim White und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, University of Michigan, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Sexual and Gender Minorities, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
False positive results in screening tests have potentially severe psychological, medical, and financial consequences for the recipient. However, there have been few efforts to quantify how the risk of a false positive accumulates over time. We seek to fill this gap by estimating the probability that an individual who adheres to the U.S. Preventive Services Task Force (USPSTF) screening guidelines will receive at least one false positive in a lifetime. To do so, we assembled a data set of 116 studies cited by the USPSTF that report the number of true positives, false negatives, true negatives, and false positives for the primary screening procedure for one of five cancers or six sexually transmitted diseases. We use these data to estimate the probability that an individual in one of 14 demographic subpopulations will receive at least one false positive for one of these eleven diseases in a lifetime. We specify a suitable statistical model to account for the hierarchical structure of the data, and we use the parametric bootstrap to quantify the uncertainty surrounding our estimates. The estimated probability of receiving at least one false positive in a lifetime is 85.5% (±0.9%) and 38.9% (±3.6%) for baseline groups of women and men, respectively. It is higher for subpopulations recommended to screen more frequently than the baseline, including more vulnerable groups such as pregnant women and men who have sex with men. Since screening technology is imperfect, false positives remain inevitable. The high lifetime risk of a false positive reveals the importance of educating patients about this phenomenon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Statistics, University of Michigan, Ann Arbor, Michigan, United States of America.
- School of Statistics, University of Minnesota, Minneapolis, Minnesota, United States of America.
ORCID-Profile: Tim White, Sara Algeri
Zitieren
APA
White, T., & Algeri, S. (2023). Estimating the lifetime risk of a false positive screening test result. PLOS ONE, 18(2), e0281153. https://doi.org/10.1371/journal.pone.0281153
Vancouver
White T, Algeri S. Estimating the lifetime risk of a false positive screening test result. PLOS ONE. 2023;18(2):e0281153. doi:10.1371/journal.pone.0281153
BibTeX
@article{White2023,
author = {White, Tim and Algeri, Sara},
title = {Estimating the lifetime risk of a false positive screening test result},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {2},
pages = {e0281153},
doi = {10.1371/journal.pone.0281153}
}
EUVIMED